Table 1_Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study.docx

Table 1_Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study.docx

Background<p>Evidence-based treatment for unresectable combined hepatocellular-cholangiocarcinoma (cHCC-CCA) has not been established. This study aimed to assess the effectiveness and safety of interventional treatment combined with immunotargeted therapy (IIT) in unresectable cHCC-CCA patient...

Full description

Saved in:
Bibliographic Details
Main Author: Yan-Song Lin (13769381) (author)
Other Authors: Li-Yan Wu (21630104) (author), Li-Hui Lin (11907245) (author), Xia Yang (46748) (author), Fang-Yi Liu (9279686) (author), Yan-Qin Wu (21630107) (author), Zhen Ding (294771) (author), Yu-Jing Liang (6164324) (author), Jing-Ping Yun (131056) (author)
Published: 2025
Subjects:
Genetic Immunology
interventional treatment
PD-(L)1 inhibitor
targeted therapy
unresectable combined hepatocellular-cholangiocarcinoma
outcome
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items